An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

JANUVIA®

Drug Information Related Patent
Hold Company
MERCK SHARP DOHME
Learn More
Dosage and Administration
TABLET;ORAL
Specification
EQ 25MG BASE; EQ 50MG BASE; EQ 100MG BASE
Indication
JANUVIA® can be used as auxiliary diet and exercise, so as to improve the adult type Ⅱ the glycemic control of diabetic patients.
Use
Instructions for Use
API
SITAGLIPTIN PHOSPHATE
API Structure
We Supply
SITAGLIPTIN PHOSPHATE
Note:

EP/USP
Facility GMP
Product GMP
ASMF/USMF/NMPA DMF

null
Note:

null

Drug Patent
Patent NoExpiration Date
73267082026/11/24
7326708*PED2027/5/24
API Patent
Patent NoExpiration Date
73267082026/11/24
7326708*PED2027/5/24

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top